Phibro Animal Health Corp
NASDAQ:PAHC

Watchlist Manager
Phibro Animal Health Corp Logo
Phibro Animal Health Corp
NASDAQ:PAHC
Watchlist
Price: 18.18 USD -1.2%
Updated: May 20, 2024
Section:
 

Relative Value

The Relative Value of one PAHC stock under the Base Case scenario is hidden USD. Compared to the current market price of 18.18 USD, Phibro Animal Health Corp is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

PAHC Relative Value
HIDDEN
Unlock
Worst Case
Base Case
Best Case

Valuation Multiples

0.7
P/S
P/S
Price to Sales
0.7
vs History
65
vs Industry
78
Median 3Y
0.7
Median 5Y
0.9
Industry
2.5
Forward
0.7
More Details
55.9
P/E
P/E
Price to Earnings
55.9
vs History
0
vs Industry
7
Median 3Y
17.8
Median 5Y
18.4
Industry
23.5
Forward
16.4
More Details
9.3
P/OCF
P/OCF
Price to OCF
9.3
vs History
80
vs Industry
37
Median 3Y
18.3
Median 5Y
16.6
Industry
17.4
More Details
23.2
P/FCFE
P/FCFE
Price to FCFE
23.2
vs History
57
vs Industry
21
Median 3Y
28.8
Median 5Y
26.1
Industry
24.3
More Details
2.7
P/B
P/B
Price to Book Value
2.7
vs History
63
vs Industry
30
Median 3Y
2.4
Median 5Y
3.4
Industry
2.1
More Details
1.1
EV/S
EV/S
Enterprise Value to Sales
1.1
vs History
65
vs Industry
71
Median 3Y
1.1
Median 5Y
1.2
Industry
2.6
Forward
1.1
More Details
3.6
EV/GP
EV/GP
Enterprise Value to Gross Profit
3.6
vs History
61
vs Industry
54
Median 3Y
3.5
Median 5Y
3.9
Industry
5.3
More Details
11.1
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
11.1
vs History
31
vs Industry
32
Median 3Y
9.7
Median 5Y
10
Industry
13.7
Forward
9.4
More Details
17.3
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
17.3
vs History
14
vs Industry
28
Median 3Y
14.3
Median 5Y
14.4
Industry
17.4
Forward
14.4
More Details
13.9
EV/OCF
EV/OCF
Enterprise Value to OCF
13.9
vs History
80
vs Industry
31
Median 3Y
24.6
Median 5Y
22
Industry
16.2
More Details
27.3
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
27.3
vs History
66
vs Industry
18
Median 3Y
25.3
Median 5Y
45.6
Industry
18.6
More Details
1.4
EV/IC
EV/IC
Enterprise Value to IC
1.4
vs History
63
vs Industry
50
Median 3Y
1.3
Median 5Y
1.6
Industry
1.9
More Details

Multiples Across Competitors

PAHC Competitors Multiples
Phibro Animal Health Corp Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Phibro Animal Health Corp
NASDAQ:PAHC
745.3m USD 0.7 55.9 11.1 17.3
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
738.5B USD 20.5 120.3 58.9 67
DK
Novo Nordisk A/S
CSE:NOVO B
4T DKK 16.5 45.1 33.6 36.9
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
366.6B USD 4.3 9.5 11.7 15.3
US
Merck & Co Inc
NYSE:MRK
332.7B USD 5.4 144.3 35.9 58.6
UK
AstraZeneca PLC
LSE:AZN
187.2B GBP 5 37.5 174.5 278.3
CH
Roche Holding AG
SIX:ROG
189B CHF 3.2 16.4 9.3 11
CH
Novartis AG
SIX:NOVN
182.7B CHF 3.4 11.5 8.7 12.7
US
Pfizer Inc
NYSE:PFE
162.2B USD 2.9 -524.9 12.7 20.6
P/E Multiple
Earnings Growth
US
Phibro Animal Health Corp
NASDAQ:PAHC
Average P/E: 55.1
55.9
76%
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
120.3
346%
DK
Novo Nordisk A/S
CSE:NOVO B
45.1
84%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
US
Johnson & Johnson
NYSE:JNJ
9.5
-21%
US
Merck & Co Inc
NYSE:MRK
144.3
7 453%
UK
AstraZeneca PLC
LSE:AZN
37.5
168%
CH
Roche Holding AG
SIX:ROG
16.4
26%
CH
Novartis AG
SIX:NOVN
11.5
15%
US
Pfizer Inc
NYSE:PFE
Negative Multiple: -524.9
680%

See Also

Summary
PAHC intrinsic value, competitors valuation, and company profile.
DCF Valuation
PAHC stock valuation using Discount Cash Flow valuation method.
Relative Valuation
PAHC stock valuation using valuation multiples.
Wall Street Estimates
PAHC price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
PAHC stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 138,900+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.